Conditions: Trichomonas Infections HIV Infections
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 270
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine if the 2 gram single dose of metronidazole is as effective as the 7 day 500 mg BID dose for treatment of Trichomonas vaginalis (TV) among HIV-infected women.

Detailed description:
This is a Phase IV equivalency trial as both doses of metronidazole are listed in the the Centers for Disease Control and Prevention Treatment Guidelines for the treatment of T vaginalis.

Arms:
arm 1: Metronidazole 2 gm single dose arm 2: Metronidazole 500 mg dose x 7 days

Interventions: intervention 1: Metronidazole
Intervention descriptions: intervention 1: 2 gm single dose versus 7 day 500 mg BID dose

Protocol document: